1. Home
  2. PCM vs BDSX Comparison

PCM vs BDSX Comparison

Compare PCM & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCM Fund Inc.

PCM

PCM Fund Inc.

HOLD

Current Price

$6.04

Market Cap

82.0M

Sector

Finance

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$10.26

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCM
BDSX
Founded
1993
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.0M
88.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PCM
BDSX
Price
$6.04
$10.26
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
29.1K
4.2M
Earning Date
01-01-0001
03-02-2026
Dividend Yield
11.68%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$80,173,000.00
Revenue This Year
N/A
$22.01
Revenue Next Year
N/A
$26.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.29
52 Week Low
$6.88
$3.44
52 Week High
$10.20
$21.60

Technical Indicators

Market Signals
Indicator
PCM
BDSX
Relative Strength Index (RSI) 45.72 57.77
Support Level $5.99 $8.69
Resistance Level $6.04 $11.49
Average True Range (ATR) 0.05 1.70
MACD 0.00 0.08
Stochastic Oscillator 38.83 54.78

Price Performance

Historical Comparison
PCM
BDSX

About PCM PCM Fund Inc.

Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: